Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omadacycline microbiome effect in healthy volunteers
NCT06030219Phase 1Completed
- Sponsor
- University of Houston
- Start
- Oct 2020
- Primary completion
- Sep 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of omadacycline in bacterial infection (3 arms), sponsored by University of Houston. Primary endpoint: Microbiome changes. Started Oct 2020; status: completed.
02
Drugs
omadacycline
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT06030219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06030219.